TransEnterix, Inc.: TransEnterix Announces Approval of Senhance Surgical System in Russian Federation
TransEnterix, Inc.: TransEnterix Announces Approval of Senhance Surgical System in Russian Federation Approval allows for marketing and sale of Senhance Surgical System for digital laparoscopy TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Senhance Surgical System has received its registration certificate by Roszdravnadzor, the Russian medical device regulatory agency allowing for its sale and utilization throughout the Russian Federation. "...